HIGHLIGHTS
- who: Rasa Liutkeviciene and collaborators from the Department of Ophthalmology, Lithuanian University of Health Sciences, Kaunas, Lithuania have published the article: Relative Leukocyte Telomere Length and Telomerase Complex Regulatory Markers Association with Leberu2019s Hereditary Optic Neuropathy, in the Journal: Medicina 2022, 1240 of 16/01/2022
- what: Evaluation of visual acuity is the primary goal in the treatment of this disease, and to date, the only approved drug for the treatment of LHON is idebenone. The authors wanted to determine whether there was a statistically significant difference in the RLTL of LHON patients who received . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.